ALBADRY SUSPENSION 40MG/ML DIN 00813516
Status: Cancelled Post Market
Holder: PHARMACIA ANIMAL HEALTH
Molecule: NOVOBIOCIN (NOVOBIOCIN SODIUM)
Available to quote
Health Canada record
| Active ingredient(s) | NOVOBIOCIN (NOVOBIOCIN SODIUM) 400 MG |
|---|---|
| Dosage form | Suspension |
| Route | Intramammary |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1984 |
| Current status date | 28-Jul-2005 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NOVOBIOCIN (NOVOBIOCIN SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00813680 | DELTA-ALBAPLEX TABLETS | PHARMACIA ANIMAL HEALTH | Tablet | NOVOBIOCIN (NOVOBIOCIN SODIUM) 60 MG; PREDNISOLONE 1.5 MG; TETRACYCLINE HYDROCHLORIDE 60 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6141 | 2002-01-15 | New Drug Submission (NDS) | |
| 6459 | 1997-07-11 | New Drug Submission (NDS) |